Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk

The Genes and Environment in Multiple Sclerosis project establishes a platform to investigate the events leading to multiple sclerosis (MS) in at‐risk individuals. It has recruited 2,632 first‐degree relatives from across the USA. Using an integrated genetic and environmental risk score, we identified subjects with twice the MS risk when compared to the average family member, and we report an initial incidence rate in these subjects that is 30 times greater than that of sporadic MS. We discuss the feasibility of large‐scale studies of asymptomatic at‐risk subjects that leverage modern tools of subject recruitment to execute collaborative projects. Ann Neurol 2016;79:178–189

[1]  A. Ascherio,et al.  Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis , 2015, Multiple sclerosis.

[2]  T. Olsson,et al.  Obesity interacts with infectious mononucleosis in risk of multiple sclerosis , 2014, European journal of neurology.

[3]  Daphne Koller,et al.  Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.

[4]  T. Olsson,et al.  Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis , 2014, Neurology.

[5]  I. Yee,et al.  The Prevalence of Familial Multiple Sclerosis in Saskatoon, Saskatchewan , 2014, Multiple sclerosis international.

[6]  M. Ramanathan,et al.  Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Patients with Multiple Sclerosis , 2014, American Journal of Neuroradiology.

[7]  Peter Szolovits,et al.  Modeling Disease Severity in Multiple Sclerosis Using Electronic Health Records , 2013, PloS one.

[8]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[9]  T. Sørensen,et al.  Childhood body mass index and multiple sclerosis risk: a long-term cohort study , 2013, Multiple sclerosis.

[10]  C. Koebnick,et al.  Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome , 2013, Neurology.

[11]  J. Lünemann,et al.  The initiation and prevention of multiple sclerosis , 2012, Nature Reviews Neurology.

[12]  J. Haselkorn,et al.  The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. , 2012, Brain : a journal of neurology.

[13]  D. Goodin,et al.  Survival in MS , 2012, Neurology.

[14]  T. Olsson,et al.  High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women , 2012, Multiple sclerosis.

[15]  P. D. de Bakker,et al.  Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci , 2011, Annals of neurology.

[16]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[17]  T. Olsson,et al.  Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.

[18]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[19]  S. Hauser,et al.  Aggregation of multiple sclerosis genetic risk variants in multiple and single case families , 2011, Annals of neurology.

[20]  J. Shulman,et al.  A Putative Alzheimer's Disease Risk Allele in PCK1 Influences Brain Atrophy in Multiple Sclerosis , 2010, PloS one.

[21]  P. Kraft,et al.  Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk , 2010, Annals of the rheumatic diseases.

[22]  Jing Cui,et al.  Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score , 2009, The Lancet Neurology.

[23]  F. Moore.  INCIDENTAL MRI ANOMALIES SUGGESTIVE OF MULTIPLE SCLEROSIS: THE RADIOLOGICALLY ISOLATED SYNDROME , 2009, Neurology.

[24]  David H. Miller,et al.  Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial , 2009, The Lancet Neurology.

[25]  F Fazekas,et al.  Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[26]  T. Olsson,et al.  Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis , 2009, Neurology.

[27]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[28]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[29]  Michael R. Johnson,et al.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. , 2009, Human molecular genetics.

[30]  G. Ebers.  Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.

[31]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[32]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[33]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[34]  V. Honti,et al.  Epidemiology of familial multiple sclerosis in Hungary , 2007, Multiple sclerosis.

[35]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[36]  M. Battaglini,et al.  Imaging brain damage in first‐degree relatives of sporadic and familial multiple sclerosis , 2006, Annals of neurology.

[37]  A. Ascherio,et al.  Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis , 2006, Annals of neurology.

[38]  M. Hernán,et al.  Cigarette smoking and the progression of multiple sclerosis. , 2005, Brain : a journal of neurology.

[39]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[40]  M. Hernán,et al.  Multiple sclerosis and age at infection with common viruses. , 2001, Epidemiology.

[41]  J. Udupa,et al.  Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals , 1999, Multiple sclerosis.

[42]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[43]  M. Rewers,et al.  Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY) , 1996, Diabetologia.

[44]  N. Risch,et al.  A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.

[45]  W. Smoker,et al.  MRI in familial multiple sclerosis , 1990, Neurology.

[46]  T. Engell.  A clinical patho‐anatomical study of clinically silent multiple sclerosis , 1989, Acta neurologica Scandinavica.

[47]  H. M. Baum,et al.  The incidence and prevalence of reported multiple sclerosis , 1981, Annals of neurology.